Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
230.02
-1.65 (-0.71%)
At close: Mar 28, 2025, 4:00 PM
235.67
+5.65 (2.46%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Labcorp Holdings Employees
Labcorp Holdings had 70,000 employees as of December 31, 2024. The number of employees increased by 3,000 or 4.48% compared to the previous year.
Employees
70,000
Change (1Y)
3,000
Growth (1Y)
4.48%
Revenue / Employee
$185,841
Profits / Employee
$10,657
Market Cap
19.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70,000 | 3,000 | 4.48% |
Dec 31, 2023 | 67,000 | -13,000 | -16.25% |
Dec 31, 2022 | 80,000 | 5,000 | 6.67% |
Dec 31, 2021 | 75,000 | 2,600 | 3.59% |
Dec 31, 2020 | 72,400 | 7,400 | 11.38% |
Dec 31, 2019 | 65,000 | 4,000 | 6.56% |
Dec 31, 2018 | 61,000 | 1,000 | 1.67% |
Dec 31, 2017 | 60,000 | 8,000 | 15.38% |
Dec 31, 2016 | 52,000 | 2,000 | 4.00% |
Dec 31, 2015 | 50,000 | 2,000 | 4.17% |
Dec 31, 2014 | 48,000 | 14,000 | 41.18% |
Dec 31, 2013 | 34,000 | 0 | - |
Dec 31, 2012 | 34,000 | 3,000 | 9.68% |
Dec 31, 2011 | 31,000 | 0 | - |
Dec 31, 2010 | 31,000 | 3,000 | 10.71% |
Dec 31, 2009 | 28,000 | 0 | - |
Dec 31, 2008 | 28,000 | 2,000 | 7.69% |
Dec 31, 2007 | 26,000 | 1,000 | 4.00% |
Dec 31, 2006 | 25,000 | 1,000 | 4.17% |
Dec 31, 2005 | 24,000 | 500 | 2.13% |
Dec 31, 2004 | 23,500 | 500 | 2.17% |
Dec 31, 2003 | 23,000 | -1,000 | -4.17% |
Dec 31, 2002 | 24,000 | 4,400 | 22.45% |
Dec 31, 2001 | 19,600 | 750 | 3.98% |
Dec 31, 2000 | 18,850 | 890 | 4.96% |
Dec 31, 1999 | 17,960 | -840 | -4.47% |
Dec 31, 1998 | 18,800 | 200 | 1.08% |
Dec 31, 1997 | 18,600 | -3,400 | -15.45% |
Dec 31, 1996 | 22,000 | -2,600 | -10.57% |
Dec 31, 1995 | 24,600 | 10,600 | 75.71% |
Dec 31, 1994 | 14,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LH News
- 18 days ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 4 weeks ago - Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors - PRNewsWire
- 6 weeks ago - Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold' - Seeking Alpha
- 7 weeks ago - Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook - Benzinga
- 7 weeks ago - Labcorp forecasts 2025 revenue above estimates on diagnostic test demand - Reuters
- 7 weeks ago - Labcorp Announces 2024 Fourth Quarter and Full Year Results - PRNewsWire
- 2 months ago - Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire